Advertisement

Topics

Cassiopea Hails Breezula's 'Good Hair Day' And Plans FDA Talks On Phase III

06:12 EDT 16 Apr 2019 | SCRIP

Italy-based Cassiopea says “very positive results” from Breezula's 12-month Phase II alopecia trial support progressing  it to Phase III, particularly given...

      

Related Stories

 

Original Article: Cassiopea Hails Breezula's 'Good Hair Day' And Plans FDA Talks On Phase III

NEXT ARTICLE

More From BioPortfolio on "Cassiopea Hails Breezula's 'Good Hair Day' And Plans FDA Talks On Phase III"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...